Business Wire

Accelera hosts Spanish Prime Minister and industry leaders for tour and meeting at Guadalajara electrolyzer facility

Share

Accelera™ by Cummins, the zero-emissions business segment of Cummins Inc. [NYSE: CMI], hosted Spanish Prime Minister Pedro Sánchez and other government officials at its state-of-the-art electrolyzer manufacturing facility in Guadalajara, Castilla-la Mancha, Spain. The visit highlighted Accelera's important role in enabling the European Union (EU) and Spain's energy transition toward a sustainable future. Following Prime Minister Sánchez’s visit, Accelera held a meeting with top industry executives to explore opportunities for advancing the Spanish green hydrogen market together.

The Government of Spain is committed to the green transition, with green hydrogen as one of its pillars. The decisive policies promoted by the Executive have allowed 20% of green hydrogen projects in Europe to be promoted in Spain.

Prime Minister Sánchez toured the 260,000 square-foot proton exchange membrane (PEM) electrolyzer manufacturing facility, one of the largest in Spain, and met with Accelera employees to celebrate their work in building the nation’s green hydrogen economy. The energy-efficient electrolyzer facility began production in April 2024 and has created 91 highly skilled jobs, with the potential for more as production expands.

Accelera is one of Spain’s leading electrolyzer manufacturers, and with one of the largest economies in the EU and its low cost of renewable energy, the country offers a strong environment for the expansion of hydrogen and electrolyzer production and export.

"We are honored to have Prime Minister Pedro Sánchez visit Accelera’s electrolyzer manufacturing plant in Guadalajara,” said Amy Davis, President of Accelera. “Our partnership with the Spanish government is key to developing the necessary infrastructure to continue scaling and innovating hydrogen technologies to achieve a zero-emissions future. Together, we are committed to advancing Spain and the EU’s green energy transition.”

Accelera recently announced its largest electrolyzer project to date – a 100-megawatt (MW) system for bp’s green hydrogen plant in Lingen, Germany – and production for the electrolyzer system is underway at the facility in Guadalajara. With an immediate 500MW of capacity, scalable to 1-gigawatt (GW), Accelera has plans to increase onsite manufacturing in the future, bringing more hydrogen production to Spain and further establishing the country as a hydrogen industrial hub in Europe.

After the Prime Minister’s visit, Accelera hosted a high-level meeting with Spain’s green hydrogen leaders to explore collaboration opportunities to accelerate Spain's position as Europe's hydrogen hub and meet the ambitious decarbonization targets set by both the country and the EU. This dialogue focused on establishing a framework for ongoing industry partnership to maximize Spain's ability to be a leader in green hydrogen production and technology development.

During the discussions, participants emphasized the importance of domestic electrolyzer production in Spain, including Accelera’s plant in Guadalajara. This production is crucial not only for reaching Spain’s target of 12 GW of installed electrolyzers, but also for creating jobs and strengthening Spain’s industrial base.

Attendees included:

  • Olvido Moraleda, President of bp Spain and Vice President of bp group
  • Arturo Gonzalo Aizpiri, CEO of Enagás
  • Millán García-Tola, Global Hydrogen Director of Iberdrola
  • José Manuel Martínez, CTO of Moeve
  • Amy Davis, President of Accelera by Cummins
  • Andreas Lippert, Vice President of Electrolyzers for Accelera by Cummins

Electrolyzers leverage renewable energy sources to produce green hydrogen, which is vital for accelerating the clean energy transition. Accelera is a leader in large-scale hydrogen production using PEM electrolysis and has deployed more than 600 electrolyzer units worldwide, powering some of the most advanced PEM electrolyzer systems operating globally. This includes a 20MW facility in Quebec, Canada, and a 25MW system in Florida, U.S.

###

About Accelera™ by Cummins

Accelera by Cummins provides a diverse portfolio of zero-emissions solutions for the world’s most economically vital industries, empowering them to accelerate the transition to a sustainable future. Accelera, a business segment of Cummins Inc., is both a components supplier and integrator, focused on batteries, e-axles, traction systems, integrated powertrain solutions, hydrogen fuel cells, and electrolyzers. Accelera currently has operations in North America, across Europe, and in China.

Cummins, a global power solutions leader, is a corporation of complementary business segments that design, manufacture, distribute, and service a broad portfolio of power solutions. Headquartered in Columbus, Indiana (U.S.), Cummins has approximately 69,900 employees and earned $3.9 billion on sales of $34.1 billion in 2024. It operates a robust distribution and support network in more than 190 countries and territories.

To learn more about Accelera by Cummins, visit accelerazero.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250318352856/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Corona Global Named Most Valuable Beer Brand in Kantar BrandZ Rankings for Second Consecutive Year15.5.2025 06:01:00 CEST | Press release

Michelob ULTRA Moves Into Top 5 Most Valuable Beer Brands GloballyAB InBev Brands Represent 8 of the Top 10 Most Valuable Beer Brands Globally Corona has been recognized as the most valuable beer brand in the world for the second consecutive year in Kantar's BrandZ 2025 Most Valuable Global Brands report, released today. Eight out of the 10 most valuable global beer brands belong to AB InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD), according to the report ranking the top brands in the world. In 2024 AB InBev produced all-time high revenue and 15% Underlying EPS growth. The year marked double-digit growth for Corona outside of its home market of Mexico and triple-digit growth of its no-alcohol brand Corona Cero. Corona Cero is the first beer brand to sponsor the Olympic Games making its debut in Paris 2024. In 2025, Corona is celebrating its 100-year anniversary with events all over the world through its “Corona 100” platform. Corona is followed by Budweiser, the second most valuab

Forrester Opens Nominations For Its 2025 B2B Awards In EMEA And APAC15.5.2025 06:00:00 CEST | Press release

Awards honor B2B organizations that drive revenue growth through effective alignment of marketing, sales, and product strategies Forrester (Nasdaq: FORR) today opened calls for nominations for its 2025 B2B Return On Integration Honors and B2B Programs Of The Year Awards in Asia Pacific (APAC) and Europe, Middle East, and Africa (EMEA). These awards will recognize B2B organizations based in both regions for achieving functional excellence and outstanding alignment across marketing, sales, and product — the B2B revenue engine — to improve customer experience and drive growth. Nominations for both award categories are open to organizations of all sizes in each region. B2B leaders across APAC and EMEA — including chief marketing officers, chief sales officers, chief product officers, and other marketing, sales, and product leaders — are invited and encouraged to apply. To be eligible, programs need to be developed by leaders and teams based in the APAC or EMEA regions. The nomination crite

Microba Announces Landmark GI Study Results From Over 4,600 Patients15.5.2025 04:12:00 CEST | Press release

Results at a glance:71.4% of MetaXplore™ reports from 4,616 patients identified actionable results41.9% tested positive for abnormal microbiome markers linked to gastrointestinal health9.9% tested positive for gastrointestinal markers, including inflammation, pancreatic insufficiency, or blood in stool19.6% of reports tested positive for multiple markers (microbiome and gastrointestinal)65% of patients reported health improvements following clinician-directed recommendations informed by MetaXplore Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”), a precision microbiome company, today announces preliminary results from the analysis of over 4,600 MetaXplore™ GI Plus test results, a comprehensive test for the assessment and management of lower gastrointestinal disorders, spanning symptoms including chronic pain, bloating, constipation, or diarrhea. This study demonstrates that MetaXplore can support clinicians to identify and address underlying gut issues that often g

Bloomstreet Enters into Strategic Partnership Agreement with Google Israel for Market Expansion in Japan15.5.2025 04:00:00 CEST | Press release

Optimizing Global Websites for the Japanese Visitors: Detailed UX/UI Adaptation, Comprehensive Japanese Localization, Extensive Localization and Cultural Relevance to Fit the Local Audience. Bloomstreet Inc. (Headquarters: Chuo-ku, Tokyo; President & CEO: Junichi Takayama; hereinafter “Bloomstreet”), a company that supports overseas enterprises entering the Japanese market, is pleased to announce a strategic partnership agreement with Google Israel Ltd. (Headquarters: Tel Aviv District; Country Manager: Barak Regev; hereinafter “Google Israel”). This partnership aims to support Israeli companies that operate globally with Google Ads and are seeking to expand into the Japanese market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250514387485/en/ How do Bloomstreet and Google Israel collaborate? The partnership between Bloomstreet and Google Israel is designed to support Israeli companies seeking to expand into the Japanese

Rubedo Life Sciences’ Drug Discovery Platform, ALEMBIC™, Helps Identify Senescent or “Zombie” Neurons in New Study Linking Neuropathic Pain and Aging Published in Peer-Reviewed Scientific Journal Nature Neuroscience15.5.2025 03:11:00 CEST | Press release

Study is the first demonstration of senescent neurons driving neuropathic pain1 Rubedo’s proprietary, AI-driven drug discovery platform ALEMBIC™ identified senescent neurons as novel therapeutic targets2 Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced that using open source codes integrated in the company’s broader propriety drug discovery platform, ALEMBIC™, helped to identify senescent neurons in a new study that found senescent neurons drive chronic pain with injury and age.1 Senescent cells, often called “zombie” cells, arise as the results of cellular stress and damage. These senescent cells do not die but undergo cellular changes, including secreting pro-inflammatory factors, thereby potentially contributing to inflammatory responses within the body.1 The study, led by Stanford University scientists, Vivianne Tawfik, MD, PhD, and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye